Irbesartan-loaded cRGD-modified PLGA nanoparticles attenuate intervertebral disc degeneration through an FGFR1-related mechanism

Authors: Yu, Xiao-Jun; Wang, Ying-Guang; Wang, Shan-Xi; Li, Ling-Jiang; Lin, Kai-Yuan; Wang, Ren-Ji; Luo, Rong-Jin; Guan, Jian-Bin; Wang, Si-Bo; Yan, Liang

Source journal: Biomarker research (2026-11-18)

DOI: 10.1186/s40364-026-01041-8

Abstract

BACKGROUND: Intervertebral disc degeneration (IDD) lacks effective disease-modifying therapy. This study evaluated the protective effects of irbesartan (Ir), explored fibroblast growth factor receptor 1 (FGFR1) as a candidate molecular mediator, and assessed whether cRGD modification could enhance nanoparticle uptake and local treatment effects. METHODS: Rat IDD models and IL-1beta-induced degenerative nucleus pulposus cells were used to assess free Ir and Ir-loaded cRGD-modified PLGA nanoparticles (cRGD-NPs@Ir). Bioinformatics screening, cellular thermal shift assay (CETSA), and molecular docking were used to nominate FGFR1 as a candidate Ir-associated protein, and FGFR1 knockdown was used to test whether FGFR1 status modified the treatment response. Imaging, histology, immunohistochemistry, Western blotting, RT-qPCR, nanoparticle characterization, Coumarin-6 uptake assays, and tandem LC3 reporter analysis were used to evaluate treatment-associated changes. RESULTS: Ir attenuated structural and molecular features of IDD, reduced MAPK/NF-kappaB signaling, altered autophagy-associated markers, and preserved extracellular matrix homeostasis. FGFR1 expression was lower in degenerative disc tissue, and FGFR1 knockdown attenuated several protective changes associated with Ir or cRGD-NPs@Ir. cRGD-NPs@Ir produced greater carrier-associated Coumarin-6 uptake than NPs@Ir and larger treatment-associated changes than free Ir for several directly compared endpoints. These findings support an FGFR1-related component of the response but do not establish direct Ir-FGFR1 binding, receptor-specific cRGD targeting, or exclusive FGFR1 dependence. CONCLUSIONS: FGFR1 may contribute as a candidate molecular mediator to Ir-associated changes in autophagy and inflammatory signaling in IDD. cRGD-NPs@Ir provides an uptake-enhancing local nanodelivery strategy, although receptor specificity and direct Ir-FGFR1 binding require further validation.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.